ArticleInternational journal of clinical and experimental pathology2019
Aquaporin 5 expression correlates with tumor multiplicity and vascular invasion in hepatocellular carcinoma.
Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach.Journal of gastrointestinal cancer · 2024Pooled it
- Aquaporin membrane channels in the hepatobiliary tract: a model of complexity and clinical implications in health and disease.Internal and emergency medicine · 2026Review
- Aquaporins in Biliary Function: Pathophysiological Implications and Therapeutic Targeting.International journal of molecular sciences · 2024Review
- Signaling Mechanisms and Pharmacological Modulators Governing Diverse Aquaporin Functions in Human Health and Disease.International journal of molecular sciences · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aquaporins (AQPs) are a family of water channel transmembrane proteins that play a key role in transcellular water movement and transport. Recent studies have reported that AQPs are involved in cancer biology and can be a novel biomarker for predicting prognosis. The aim of this study was to identify clinical significance and prognostic impact of AQP5 in surgically resected hepatocellular carcinomas (HCCs). We analyzed the association between the expression of AQP5, Ki-67, and E-cadherin. Immunohistochemical stains for AQP5, KI-67, and E-cadherin were performed on 72 surgically resected HCCs. As a result, 46 patients (63.9%) showed AQP5 expression, 46 patients (63.9%) revealed high expression of Ki-67, and E-cadherin loss was identified in 8 patients (11.1%). No significant relationship among the three markers was found (all P > 0.05). AQP5 expression was associated with tumor multiplicity (P = 0.039), microvascular invasion (P = 0.040), and major vessel invasion (P = 0.044). High expression of Ki-67 was related to high serum AFP level (P = 0.006), tumor grade (P = 0.002), and microvascular invasion (P = 0.040). AQP5 expression tended to be associated with worse overall survival (OS) (P = 0.093) in the univariate analysis, but no significance was found in the multivariate survival analysis. High expression of Ki-67 was associated with shorter recurrence-free survival (RFS) in both univariate (P = 0.012) and multivariate analysis (P = 0.020). In conclusion, AQP5 might be a prognostic marker in HCC based on its association with tumor multiplicity, microvascular invasion, and major vessel invasion; and Ki-67 is an independent prognostic factor in HCC.
Indexed as
Identifiers
31933856PMC6945080W3008246456What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.